|
1
|
Weinert LS: International association of
diabetes and pregnancy study groups recommendations on the
diagnosis and classification of hyperglycemia in pregnancy: Comment
to the International Association of Diabetes and Pregnancy Study
Groups Consensus Panel. Diabetes Care. 33:676–682. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mitanchez D: Foetal and neonatal
complications in gestational diabetes: Perinatal mortality,
congenital malformations, macrosomia, shoulder dystocia, birth
injuries, neonatal complications. Diabetes Metab. 36:617–627. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mitanchez D, Burguet A and Simeoni U:
Infants born to mothers with gestational diabetes mellitus: Mild
neonatal effects, a long-term threat to global health. J Pediatr.
164:445–450. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wright CS, Rifas-Shiman SL, Rich-Edwards
JW, Taveras EM, Gillman MW and Oken E: Intrauterine exposure to
gestational diabetes, child adiposity, and blood pressure. Am J
Hypertens. 22:215–220. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bellamy L, Casas JP, Hingorani AD and
Williams D: Type 2 diabetes mellitus after gestational diabetes: A
systematic review and meta-analysis. Lancet. 373:1773–1779. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Retnakaran R, Qi Y, Sermer M, Connelly PW,
Hanley AJ and Zinman B: Beta-cell function declines within the
first year postpartum in women with recent glucose intolerance in
pregnancy. Diabetes Care. 33:1798–1804. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kramer CK, Swaminathan B, Hanley AJ,
Connelly PW, Sermer M, Zinman B and Retnakaran R: Each degree of
glucose intolerance in pregnancy predicts distinct trajectories of
beta-cell function, insulin sensitivity, and glycemia in the first
3 years postpartum. Diabetes Care. 37:3262–3269. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Buchanan TA and Xiang AH: Gestational
diabetes mellitus. J Clin Invest. 115:485–491. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bergrem H and Leivestad T: Diabetic
nephropathy and end-stage renal failure: The Norwegian story. Adv
Ren Replace Ther. 8:4–12. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wong CK, Ho AW, Tong PC, Yeung CY, Kong
AP, Lun SW, Chan JC and Lam CW: Aberrant activation profile of
cytokines and mitogen-activated protein kinases in type 2 diabetic
patients with nephropathy. Clin Exp Immunol. 149:123–131. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tuttle KR: Linking metabolism and
immunology: Diabetic nephropathy is an inflammatory disease. J Am
Soc Nephrol. 16:1537–1538. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Beharier O, Shoham-Vardi I, Pariente G,
Sergienko R, Kessous R, Baumfeld Y, Szaingurten-Solodkin I and
Sheiner E: Gestational diabetes mellitus is a significant risk
factor for long-term maternal renal disease. J Clin Endocrinol
Metab. 100:1412–1416. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Friedman S, Rabinerson D, Bar J, Erman A,
Hod M, Kaplan B, Boner G and Ovadia J: Microalbuminuria following
gestational diabetes. Acta Obstet Gynecol Scand. 74:356–360. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ainuddin J, Karim N, Hasan AA and Naqvi
SA: Metformin versus insulin treatment in gestational diabetes in
pregnancy in a developing country: A randomized control trial.
Diabetes Res Clin Pract. 107:290–299. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Barrett HL, Gatford KL, Houda CM, De
Blasio MJ, McIntyre HD, Callaway LK, Dekker Nitert M, Coat S, Owens
JA, Hague WM and Rowan JA: Maternal and neonatal circulating
markers of metabolic and cardiovascular risk in the metformin in
gestational diabetes (MiG) trial: Responses to maternal metformin
versus insulin treatment. Diabetes Care. 36:529–536. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rowan JA, Hague WM, Gao W, Battin MR and
Moore MP; MiG Trial Investigators, : Metformin versus insulin for
the treatment of gestational diabetes. N Engl J Med. 358:2003–2015.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Matthews DR, Hosker JP, Rudenski AS,
Naylor BA, Treacher DF and Turner RC: Homeostasis model assessment:
Insulin resistance and beta-cell function from fasting plasma
glucose and insulin concentrations in man. Diabetologia.
28:412–419. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lapsley M, Flynn FV and Sansom PA: Beta
2-glycoprotein-1 (apolipoprotein H) excretion and renal tubular
malfunction in diabetic patients without clinical proteinuria. J
Clin Pathol. 46:4651993. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Berrut G, Bouhanick B, Fabbri P,
Guilloteau G, Bled F, Le Jeune JJ, Fressinaud P and Marre M:
Microalbuminuria as a predictor of a drop in glomerular filtration
rate in subjects with non-insulin-dependent diabetes mellitus and
hypertension. Clin Nephrol. 48:92–97. 1997.PubMed/NCBI
|
|
20
|
Lobner K, Knopff A, Baumgarten A,
Mollenhauer U, Marienfeld S, Garrido-Franco M, Bonifacio E and
Ziegler AG: Predictors of postpartum diabetes in women with
gestational diabetes mellitus. Diabetes. 55:792–797. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kessous R, Shoham-Vardi I, Pariente G,
Sherf M and Sheiner E: An association between gestational diabetes
mellitus and long-term maternal cardiovascular morbidity. Heart.
99:1118–1121. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jawerbaum A and White V: Animal models in
diabetes and pregnancy. Endocr Rev. 31:680–701. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Caluwaerts S, Holemans K, van Bree R,
Verhaeghe J and Van Assche FA: Is low-dose streptozotocin in rats
an adequate model for gestational diabetes mellitus? J Soc Gynecol
Investig. 10:216–221. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Holemans K, Caluwaerts S, Poston L and Van
Assche FA: Diet-induced obesity in the rat: A model for gestational
diabetes mellitus. Am J Obstet Gynecol. 190:858–865. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chengya L, Kristi DC and Prater MR:
High-saturated-fat diet induces gestational diabetes and placental
vasculopathy in C57BL/6 mice. Metabolism. 59:943–950. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rowan JA, Rush EC, Obolonkin V, Battin M,
Wouldes T and Hague WM: Metformin in gestational diabetes: the
offspring follow-up (MiG TOFU): Body composition at 2 years of age.
Diabetes Care. 34:2279–2284. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Committee on Practice
Bulletins-Obstetrics: Practice Bulletin No. 137: Gestational
diabetes mellitus. Obstet Gynecol. 122:406–416. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hod M, Kapur A, Sacks DA, Hadar E, Agarwal
M, Di Renzo GC, Cabero Roura L, McIntyre HD, Morris JL and Divakar
H: The International Federation of Gynecology and Obstetrics (FIGO)
Initiative on gestational diabetes mellitus: A pragmatic guide for
diagnosis, management, and care. Int J Gynaecol Obstet. 131 (Suppl
3):S173–S211. 2015. View Article : Google Scholar
|
|
29
|
Bomback AS, Rekhtman Y, Whaley-Connell AT,
Kshirsagar AV, Sowers JR, Chen SC, Li S, Chinnaiyan KM, Bakris GL
and McCullough PA: Gestational diabetes mellitus alone in the
absence of subsequent diabetes is associated with microalbuminuria:
Results from the Kidney Early Evaluation Program (KEEP). Diabetes
Care. 33:2586–2591. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Moriya T, Matsubara M, Kishihara E,
Yoshida Y and Ouchi M: Type 2 diabetic patients with diabetic
retinopathy and concomitant microalbuminuria showed typical
diabetic glomerulosclerosis and progressive renal dysfunction. J
Diabetes Complications. 30:1111–1116. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
American Diabetes Association: Standards
of medical care in diabetes-2012. Diabetes Care. 35 (Suppl
1):S11–S63. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stanga Z, Nock S, Medina-Escobar P,
Nydegger UE, Risch M and Risch L: Factors other than the glomerular
filtration rate that determine the serum beta-2-microglobulin
level. PLoS One. 8:e720732013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gregor MF and Hotamisligil GS:
Inflammatory mechanisms in obesity. Ann Rev Immunol. 29:415–445.
2011. View Article : Google Scholar
|
|
34
|
Muller S, Martin S, Koenig W,
Hanifi-Moghaddam P, Rathmann W, Haastert B, Giani G, Illig T,
Thorand B and Kolb H: Impaired glucose tolerance is associated with
increased serum concentrations of interleukin 6 and co-regulated
acute-phase proteins but not TNF-alpha or its receptors.
Diabetologia. 45:805–812. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kirwan JP, Hauguel-De Mouzon S, Lepercq J,
Challier JC, Huston-Presley L, Friedman JE, Kalhan SC and Catalano
PM: TNF-alpha is a predictor of insulin resistance in human
pregnancy. Diabetes. 51:2207–2213. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cargnello M and Roux PP: Activation and
function of the MAPKs and their substrates, the MAPK-activated
protein kinases. Microbiol Mol Biol Rev. 75:50–83. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shanmugam N, Reddy MA, Guha M and
Natarajan R: High glucose-induced expression of proinflammatory
cytokine and chemokine genes in monocytic cells. Diabetes.
52:1256–1264. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen YY, Chen J, Hu JW, Yang ZL and Shen
YL: Enhancement of lipopolysaccharide-induced toll-like receptor 2
expression and inflammatory cytokine secretion in HUVECs under high
glucose conditions. Life Sci. 92:582–588. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kuzmicki M, Telejko B, Zonenberg A,
Szamatowicz J, Kretowski A, Nikolajuk A, Laudanski P and Gorska M:
Circulating pro- and anti-inflammatory cytokines in Polish women
with gestational diabetes. Horm Metab Res. 40:556–560. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tao L, Li D, Liu H, Jiang F, Xu Y, Cao Y,
Gao R and Chen G: Neuroprotective effects of metformin on traumatic
brain injury in rats associated with NF-κB and MAPK signaling
pathway. Brain Res Bull. 140:154–161. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lei Y, Yi Y, Liu Y, Liu X, Keller ET, Qian
CN, Zhang J and Lu Y: Metformin targets multiple signaling pathways
in cancer. Chin J Cancer. 36:172017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Mackenzie RW and Elliott BT: Akt/PKB
activation and insulin signaling: A novel insulin signaling pathway
in the treatment of type 2 diabetes. Diabetes Metab Syndr Obes.
7:55–64. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ferreira GD, Germeyer A, de Barros Machado
A, do Nascimento TL, Strowitzki T, Brum IS, von Eye Corleta H and
Capp E: Metformin modulates PI3K and GLUT4 expression and Akt/PKB
phosphorylation in human endometrial stromal cells after
stimulation with androgen and insulin. Eur J Obstet Gynecol Reprod
Biol. 175:157–162. 2014. View Article : Google Scholar : PubMed/NCBI
|
